chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I received my first dose listed above on 12/28/20.  I received my second dose listed above on 1/25/21.  I had little reaction to either dose.  However, I started having symptoms including sinus pressure/ congestion and headache and I tested positive for Covid on 7/29/2021,  My employer requested that I submit this to you to notify you of the occurrence after being fully vaccinated for several months.
Pyrexia; Headache; Fatigue; Ache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Ache), PYREXIA (Pyrexia), HEADACHE (Headache) and FATIGUE (Fatigue) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028A02A and 002A21A.) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No Significant Medical History). Concomitant products included NEBIVOLOL HYDROCHLORIDE (BYSTOLIC), MELOXICAM, ANASTROZOLE (ANASTRAZOLE DENK), VITAMIN D [VITAMIN D NOS] and MULTIVITAMINS [VITAMINS NOS] for an unknown indication.   On 01-Mar-2021 at 10:15 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PAIN (Ache). On 29-Mar-2021 at 11:00 PM, the patient experienced PYREXIA (Pyrexia), HEADACHE (Headache) and FATIGUE (Fatigue). At the time of the report, PAIN (Ache), HEADACHE (Headache) and FATIGUE (Fatigue) outcome was unknown and PYREXIA (Pyrexia) had not resolved.            Treatment Medicines include Tylenol and Meloxicam  Action taken with mRNA-1273 in response to the event was not applicable
8/24/14 pt was seen in Prompt care for fevers after shot. Follow up in office, showed apthous ulcers in mouth, afebrile.
pt recvd vax 23SEP93 & 2 days later devel achiness, rhinorrhea, cough & a low grade fever which lasted for 2 days;
Received shot and W/H KeD to intake area my whole arm became numb, I felt dizzy and sat down, I felt faint and put my head on the desk. I started sweating, shaking and my heart started racing. When I started to come out of it, I felt weak, tired and shaky. I went home and slept for 2-3 hours took Advil for aches and headache behind my eye.
Information has been received from a health professional via a Pharmacist concerning a patient who on an unspecified date was vaccinated with pneumococcal 23v polysaccharide vaccine (lot# unknown). Subsequently the patient experienced an unspecified reaction. Medical attention was sought. No other information was available. At the time of reporting it was unknown if the patient had recovered.
Woke up following morning unable to move right arm.  Pain radiated from the shoulder all the way down.  Received several cortisone shots into shoulder for inflammation once every 4 weeks for 3 months  but still have some problems with flare ups & pain
High grade fever - Temperature at 104.6 F at 5:10 pm - decreased to 103.1 F in 10-15 mins.  Patient had afebrile seizure later that night - EMS called - taken to ER.  Postictal, no other abnormalities found.  Fever and vomiting started 02/05/08 daytime.
pt recvd vax;RN stated that mom said pt broke out w/ water blister pimples over arms & legs;approx 27sep95 devel 5 pox & inc fever of 101.8;pt's father had shingles 2 wks a/;
tightness in chest, lt arm numbness, h/a, wheezing about 40min p/shot;convuls about 1hr p/shot w/rapid pulse & high BP;
hot flashes; Muscle Pain, particularly in neck, arms and back/ Muscular pain in lower back that is gradually getting worse; persistent and constant headaches, particularly after awaking from sleep and near bedtime; shivers; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 27 year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 04Nov2021 07:30 (Lot number: FF8841) at the age of 27 years as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: EL3248, Location of injection: Arm Left, Vaccine Administration Time: 07:00, Route of Administration: Intramuscular), administration date: 02Feb2021, when the patient was 27 years old, for Covid-19 immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: EL3248, Location of injection: Arm Left, Vaccine Administration Time: 07:00, Route of Administration: Intramuscular), administration date: 14Jan2021, when the patient was 27 years old, for Covid-19 immunization. The following information was reported: HOT FLUSH (non-serious) with onset 04Nov2021 18:00, outcome "unknown", described as "hot flashes"; MYALGIA (non-serious) with onset 04Nov2021 18:00, outcome "unknown", described as "Muscle Pain, particularly in neck, arms and back/ Muscular pain in lower back that is gradually getting worse"; HEADACHE (non-serious) with onset 04Nov2021 18:00, outcome "unknown", described as "persistent and constant headaches, particularly after awaking from sleep and near bedtime"; CHILLS (non-serious) with onset 04Nov2021 18:00, outcome "unknown", described as "shivers". It was unknown if therapeutic measures were taken as a result of hot flush, myalgia, headache, chills.  Additional information: The patient did not have covid prior vaccination and covid was not tested post vaccination and did not have any known allergies.  Follow-up attempts are completed. No further information is expected.
Feb 6. 2013 about 1 hr after leaving, I started feeling sick/nausea and noticed my arm was irritated, red & stiff.
Vomiting/vomiting 6 times within 4 hours/The vomiting has resolved; Headache; Warm to touch; This case was reported by a nurse via call center representative and described the occurrence of skin warm in a 16-year-old female patient who received Men B NVS (Bexsero) (batch number 5p2t7, expiry date 31st January 2026) for prophylaxis.   Co-suspect products included meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 3rd January 2023, the patient received the 2nd dose of Bexsero and Bexsero Pre-Filled Syringe Device. On 3rd January 2023, 1 hr after receiving Bexsero and Bexsero Pre-Filled Syringe Device, the patient experienced vomiting and headache. In January 2023, the patient experienced skin warm. On an unknown date, the outcome of the skin warm was unknown and the outcome of the vomiting was recovered/resolved and the outcome of the headache was not recovered/not resolved.   It was unknown if the reporter considered the skin warm, vomiting and headache to be related to Bexsero and Bexsero Pre-Filled Syringe Device. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 04-JAN-2023 Reporter's comments: The nurse had reported that a 16 year old patient who had received her second dose of Bexsero a day before reporting.  Within one hour, the patient had experienced a headache and vomiting (vomiting 6 times within 4 hours). The patient was also warm to touch and according to the patient mother who was also an MD. No temperature was available. At the time of reporting the vomiting has resolved but not the headache. The reporter had consented to follow-up. Additional supportive information:  Less than an week after receiving Bexsero and Bexsero Pre-Filled Syringe Device, the patient experienced skin warm.
patient got shot Thursday am 10/7, but Saturday morning 10/9 was experiencing underarm tenderness/pains in underarm on left side and swollen lymph nodes, temporarily lost feeling in left arm...also had some shortness of breath on sunday that has since resolved, and some diarrhea on Monday
Initial information received on 05-Nov-2018 regarding an unsolicited valid non-serious case received from a consumer/non-hcp. This case involves patient who experienced inject reactions, while he/she received vaccine ADACEL. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received a dose of suspect DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE lot number not reported. The patient developed a non-serious inject reactions (injection site reaction) following the administration of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE. (Other relevant tests included No lab test.) Final diagnosis was inject reactions. It was not reported if the patient received a corrective treatment. The patient outcome is reported as Unknown for inject reactions.
11/12/2021:  COVID-19 pneumonia with hypoxia 58 year old woman was sent from infusion clinic for hypoxia.  The patient became symptomatic with cough, loss of taste and smell starting Nov 4th.  She believes she became infected from a nephew who gave about 10 people in her home COVID.  She also had loss of taste and smell but those returned Nov 11th.  The patient tested positive on Nov 8th.  She came into the infusion clinic for her Regeneron dose and was noticed to be hypoxic AFTER her infusion down to the mid 80s with ambulation.  At rest, her oxygen sat was around 90%.  She denies CP, palpitations, HA, dizziness, diarrhea.  She did have a very strong and persistent cough.  She denies emesis.  She is being admitted for further treatment of her COVID with hypoxia.  As of the submission of this report, the patient is still hospitalized.
Site: Swelling at Injection Site-Mild, Additional Details: Patient states she noticed redness in the interior area of her arm, close to her axilla area, not on her deltoid where the vaccine was administered. Patient was concerned since this occurred 2 days after her Tdap vaccine
Started with chills and body aches on the 4th day. Pain level increased by midnight, unable to sleep. Took Ibuprofen. By the 5/6th day, severe pain, fatigue, no appetite, little nausea, and occasional low degree fever (99-101F) Alternated Ibuprofen and Acetaminophen every 5 hours. 8th day around 9pm, left arm went numb and tingling at the fingertips. 9th day, appetite is back and feels back to self.
"Pt w/ allergy to Kiwi (unspecified rxn). PMH: Obesity Hypercholesteremia Gender dysphoria Depression Anxiety  Current Medications: Testosterone 50mg IM Qweek Qvar 80mcg/act 3inh BID Albuterol 2 inh Q4hrs PRN wheezing or SOB  2mins post vaccination pt had a syncopal episode with flushing/sweating, pinched nerve pain, and dizziness.  BP 138/85, HR 100, RR 16.  Pt symptoms improved over 30 mins. Pt stable and released from the vaccination site @15:00."
Expired Havrix administered; This case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a patient who received HAV (Havrix) (batch number 7YA99, expiry date 30th September 2022) for prophylaxis.   On 1st February 2023, the patient received Havrix. On 1st February 2023, unknown after receiving Havrix, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   Additional Information: GSK Receipt date: 13-Feb-2023 Reporter's Comment: Reporter stated administration of an expired dose of Havirix to a patient. Pharmacist declined to provide any patient demographics. The reporter consented to follow-up. Additional Supportive Information: The patient received an expired Havrix vaccine, which led to expired vaccine used.
Severe chills and body aches lasted about 5 hours, fatigue for the next 24hours.  Took Tylenol and rest.  Feel fine now.
Information has been received from a registered nurse concerning a patient who on 27-AUG-1998 was vaccinated with a dose of Varivax. Subsequently, on 09-MAR-2006, the patient developed breakthrough varicella. Unspecified medical attention was sought. There was no product quality complaint. No additional information is expected.
Can only eat a little; Pain in hand; She cant lift up her left arm; Vomiting; Pain in wrist; Arm started hurting; Shoulder felt like it was on fire to rib cage through collarbone down to hand; Temperature of 102; Shivers; Diarrhoea; Urinating a lot; Injection more in shoulderthan arm; A spontaneous report was received from consumer concerning a 70 year female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced injection was administered in shoulder more than arm (product administered at inappropriate site), arm started hurting (pain in arm) , shoulder felt like it was on fire to rib cage through collarbone down to hand (burning sensation), had temperature of 102 (pyrexia), shivers (chills), vomiting (vomiting), urinating a lot (urine output increased), diarrhea (diarrhea), pain in wrist (arthralgia) and hand (pain in hand), she cannot lift up her left arm (vaccination site movement impairment), and can only eat a little (decreased appetite),.  The patient's medical history included allergies. Concomitant product use was not reported.  On 02 Mar 2021, the patient received their first of two planned doses of mRNA-1273 (Lot number: not provided) intramuscularly for prophylaxis of COVID-19 infection in shoulder more than her arm. On 02 Mar 2021, same day of receiving vaccine, the patient experienced arm started hurting (pain in arm), shoulder felt like it was on fire to rib cage through collarbone down to hand, had temperature of 102, shivers, vomiting, urinating a lot, and diarrhea. On 03 Mar 2021, next day of receiving vaccine, the patient experienced pain in wrist, hand pain, unable to lift up her left arm, and she was only able to eat a little.  Treatment information was not provided.  Action taken with mRNA-1273 with respect to the events was not reported.  The outcome of the event, vaccine administered at inappropriate site was considered resolved and for the remaining events, it was not reported.  The reporter did not provide the causality assessment for the events.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. This report also refers to a case of product administered at inappropriate site for mRNA-1273 (lot # unknown), with no associated AEs. Further information has been requested.
5 minutes after giving JJ vaccine. Patient came to counter and said he needed to lie down bc he was feeling faint. I instructed him to lie down and by the time I got to him he had fainted. He was out for a few seconds. He remained lying down and felt dizzy. But was uninjured.
Patient received the Janssen  COVID vaccine. She left the room and shortly after came to the window saying  she felt faint, light headed, dizzy, and sweaty. She also reported her hearing fading in and out. I took her back into our immunization room and had her sit down. She had no visible signs on the injection site of a reaction. She did appear pale. I gave her an ice pack and placed on her and a technician gave her some water. She placed her head between her knees for a bit as well. Probably about 10 min after she felt better. She decide she was well enough to get up and decided to wait an additional 5-10min outside of the pharmacy before leaving.
Days 1-4: Headache Days 1-4 of ?feeling off?: Shortness of breath while climbing stairs and/or routine motion -Tightness in chest -Unable to catch breath and increased discomfort  Day 4: Tightness in Right calf, back of leg. Feeling like a ?Charlie horse not going away? Day 5: All of the above, drove myself to local Urgent Care where I was instructed to go to the ER
Patient reports receiving a flu shot that was a regular flu shot plus protection from H1N1 (approximately November 2010). Woke up the next morning and had full body red rash and itching. Went to outside clinic and received Z-PACK, cimetidine, and diphenhydramine.
Patient did not initially wait in waiting room after shot like instructed. Patient went with mother to check out groceries and suddenly felt faint. The mother brought her back to the pharmacy and very pale, warm, loss of color in lips. We had her lay down, with feet elevated and cold pack to forehead.  After 5-10 minutes started feeling "better". She reported that she hadn't eaten anything all day. We gave her a can of cold punch of which she did drink.  Patient reported buzzing in ears but it went away.  Lip color returned, pt was not warm to touch, and felt "good enough" to walk to the car.   The Mother took the punch, cold pack, and a bottled water with her.
Information has been received from a Nurse Practitioner concerning a 19 year old white female who on 25-JAN-2007 was vaccinated intramuscularly with Gardasil (lot number not provided). On 28-JAN-2007 the patient experienced injection site pain and fatigue and developed pruritus and hives on her whole body. The patient was seen on an unspecified date by her primary care physician (contact information not provided) and treated with Vistaril 50 mg, PO every 6 hours and "comfort measures". On an unspecified date the patient was considered to have recovered from the hives, injection site pain and fatigue. The reporter considered the pruritus and hives to be serious other medical events. Additional information has been requested.
Swollen hot arm; Cold; Cannot sleep all night; No energy; Fever; Fatigue; Aching body; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swollen hot arm), NASOPHARYNGITIS (Cold), INSOMNIA (Cannot sleep all night), ASTHENIA (No energy) and PYREXIA (Fever) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. HRSO311321A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included VITAMIN D [VITAMIN D NOS] and SALBUTAMOL SULFATE for an unknown indication.   On 01-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (Swollen hot arm), NASOPHARYNGITIS (Cold), INSOMNIA (Cannot sleep all night), ASTHENIA (No energy), PYREXIA (Fever), FATIGUE (Fatigue) and MYALGIA (Aching body). At the time of the report, PERIPHERAL SWELLING (Swollen hot arm), NASOPHARYNGITIS (Cold), INSOMNIA (Cannot sleep all night), ASTHENIA (No energy), PYREXIA (Fever), FATIGUE (Fatigue) and MYALGIA (Aching body) outcome was unknown.            Treatment information was not provided. Action taken with mRNA-123 is not applicable.
Patient started experiencing facial tingling and shortness of breath within 10 minutes of vaccine administration. Patient had a history of anaphylaxis reaction and carried their own epipen and benadryl in case of emergencies. Patient immediately administered the Epipen and then administered 25mg of oral benadryl prior to EMS arriving . EMS arrived within 5 minutes of patient administering  Epipen and benadryl. Patient's full recovery was monitored by EMS  and patient departed the pharmacy with spouse.
Right sided lymph node swelling (submental and submandibular), with soreness at swollen sites.
I did not have a reaction to the vaccine. I tested positive for COVID-19 on 06/09/2022 via a home test and a PCR test after being on a family vacation. I had soreness in my throat and congestion. I contacted my primary care physician and was given the prescription PAXLOVID. I took all the medication and tested negative for COVID-19 but a few days later I tested positive again. The symptoms didn't last long and I didn't take anything to relieve the symptoms.
Client called 4/27 and left voice mail stating she was weak and dizzy at times starting on 4/27. Went to school 4/27 but feeling like she had a temperature but felt very cold. Returned call around 3 P.M. 4/26: Had not eaten since early A.M., not drinking much fluid. Suggested rest and encouraged protein and carb meal and 40 ounces of liquid. At 4:30 PM Called client to follow-up: Mother answered the phone. Daughter had a temp of 100.7 and asleep on the couch. Did not eat much snack. Will call 4/28. Called 4/28: Spoke to client's father as daughter went to school today. Reported she felt much better. Mentioned that there was a recent death in the family with close relative. VAERS completed and mailed.
25 minutes after I left from getting the injection, I started getting a headache when I got home I took an aspirin got really tired went to bed early Sunday woke up with another headache my arm hurts so bad I couldn?t lift it. I had such aches and pains in my joints.Took some more aspirin felt better after about three or four hours woke up this morning feeling refreshed. My doctor?s nurse said the booster might be a little worse. I emailed them told him how I felt after I had the injection and my doctor?s nurse called me this morning
1st dose 1 year ago, 2nd shot 4 weeks ago; This case was reported by a consumer via call center representative and described the occurrence of drug dose administration interval too long in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (Family History) (patient's wife had shingles 5 weeks ago). Previously administered products included Shingles shot (received 1st shot 1 year ago).   In November 2022, the patient received the 2nd dose of Shingles vaccine. In November 2022, unknown after receiving Shingles vaccine, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown.   Additional Information: GSK receipt date: 7-Dec-2022 Reporter's comment: The reporter did not provided patient's initials and date of birth. The reporter also asked that she got shingles 5 weeks ago and how long should she wait to get the shingles shot as she was on antiviral within 8 hours of discovering shingles. The reporter also stated that she had shingles so did not had really bad. The reporter did not consent to follow-up. Additional supportive information: The patient received the 2nd shot later than the recommended schedule, which led to lengthening of vaccine schedule.
Hospitalization for COVID pneumonia 8/19-8/22/21. Treated with dexamethasone and Remdesivir.
6 months after received Daptacel, in May of 2005, the patient experienced a cough.  She was seen in a physician's office.  The physician stated that there is an outbreak of pertussis in Tucson.  Due to the outbreak of pertussis, the patient was tested for antibodies to pertussis.  Subsequently on 05/24/2005 the results of the pertussis antibody titer was negative.  The patient's outcome was not reported.
muscle aches not more than usual, family DR is following my condition.  not related to vaccine.  these are normal problems for me
Covid-19 Vaccine EUA; Woke with a headache on day 7, took two Tylenol and headache went away. Developed a red rash on the left arm near the injection site which became itchy, heated and irritated.  Used Bacitracin Antibiotic topical Ointment,  later Anti-Itch Cream from Thursday until Friday and then Saturday, 01/23/2021 to present used Benadryl Original Strength Topical Analgesic skin protectant cream.  With use of the Benadryl rash/itchiness appears much improved on 01/24/2021.
Ischemic stroke affecting right side of body. Left partial numbness on right side limbs. body and face. Most numbness has subsided. Caused blind spot in right eye, which has been corrected/healed.
Facial paralysis, fluttering in left ear. Was prescribed Anti-viral medication by healthcare provider.